title: Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007-2008.
abstract: Successive point prevalence surveys were conducted in November 2007 and 2008 to monitor the prevalence of healthcare-associated infection (HCAI) in 13 grade III, 1st class hospitals in Hubei Province of China, using the case definition criteria established by the Ministry of Health in the People's Republic of China. In total, of 20 350 patients surveyed, 833 (4.09%) HCAIs were observed in 790 (3.88%) patients. There was no significant difference between the overall prevalence of HCAI in 2007 (4.14%) and 2008 (3.72%). Respiratory tract infection was the most common HCAI (63.15%), followed by surgical site infection (9.60%) and urinary tract infection (8.64%). Only 35.29% (294/833) of HCAI patients had positive microbiology results. Gram-negative bacteria were isolated most frequently and the most frequent organism was Pseudomonas aeruginosa, followed by Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus. Antibiotic use was documented for 10,344 (50.83%) patients, and cephalosporins, penicillins, and quinolones were the most commonly used agents for treatment or prophylaxis.
authors.affiliation: Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
authors.forename: Duo-shuang
authors.initials: DS
authors.lastname: Xie
authors.forename: Wei
authors.initials: W
authors.lastname: Xiong
authors.forename: Li-li
authors.initials: LL
authors.lastname: Xiang
authors.forename: Xiang-yun
authors.initials: XY
authors.lastname: Fu
authors.forename: Yuan-hua
authors.initials: YH
authors.lastname: Yu
authors.forename: Li
authors.initials: L
authors.lastname: Liu
authors.forename: Shu-qiong
authors.initials: SQ
authors.lastname: Huang
authors.forename: Xiao-hui
authors.initials: XH
authors.lastname: Wang
authors.forename: Xiu-min
authors.initials: XM
authors.lastname: Gan
authors.forename: Min
authors.initials: M
authors.lastname: Xu
authors.forename: Hong-bo
authors.initials: HB
authors.lastname: Wang
authors.forename: Hao
authors.initials: H
authors.lastname: Xiang
authors.forename: Yi-hua
authors.initials: YH
authors.lastname: Xu
authors.forename: Shao-fa
authors.initials: SF
authors.lastname: Nie
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D003428:Cross Infection / Q000453:epidemiology*; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012141:Respiratory Tract Infections / Q000453:epidemiology; D013530:Surgical Wound Infection / Q000453:epidemiology; D014552:Urinary Tract Infections / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents